
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1011 | 1019 | 1086 | 1081 | 1083 | - |
Fund Return | 1.14% | 1.94% | 8.58% | 2.62% | 1.61% | - |
Place in category | 782 | 600 | 339 | 757 | 634 | - |
% in Category | 78 | 55 | 30 | 86 | 86 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JH Horizon Euro Corporate Bond I2 | 115.14M | 1.10 | 0.39 | 0.93 | ||
LU0451950314 | 129.42M | 1.04 | -0.04 | 0.51 | ||
S Horizon Global High Yield Bond F2 | 46.62M | 1.22 | 1.63 | 2.76 | ||
S Horizon Global High Yield Bond F3 | 31.22M | 1.19 | 1.61 | 2.76 | ||
S Horizon Global High Yield Bond Fe | 57.15M | 1.28 | 2.04 | 3.18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Euro High Yield Class C EUR Cap | 3.21B | 0.98 | 4.64 | 3.41 | ||
Euro High Yield Class C EUR Dis | 3.21B | 0.97 | 4.58 | 3.33 | ||
Euro High Yield Class I EUR Cap | 3.21B | 1.11 | 5.15 | 3.81 | ||
Euro High Yield Class N EUR Cap | 3.21B | 0.94 | 4.28 | 3.03 | ||
Euro High Yield Class R EUR Cap | 3.21B | 1.08 | 5.18 | 3.87 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Euro Schatz Future June 25 | DE000F1B2NJ1 | 6.91 | - | - | |
Euro Bobl Future June 25 | DE000F1B2NH5 | 6.48 | - | - | |
Teva Pharmaceutical Finance Netherlands II B.V 4.375% | XS2406607171 | 2.13 | - | - | |
Telefonica Europe B V 2.88% | XS2410367747 | 1.68 | - | - | |
Castellum AB 3.125% | XS2380124227 | 1.55 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Sell |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Strong Sell | Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review